{"id":"W2526843003","doi":"10.1164/rccm.201602-0300oc","title":"Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors","year":2016,"lang":"en","type":"article","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Population and Public Health; Institute of Cancer Research","funders":"National Research Program for Biopharmaceuticals; National Health Research Institutes; National Science Council","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Single-nucleotide polymorphism; Hazard ratio; Epidermal growth factor receptor; Adenocarcinoma; Progression-free survival; Cohort; Tyrosine kinase; Gefitinib; Cancer research; Cancer; Chemotherapy; Gene; Genotype; Receptor; Biology; Genetics; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002910416,0.0002184865,0.0002469579,0.000351321,0.0002960991,0.0002876508,0.0002734264,0.0005288349,0.00134131],"category_scores_gemma":[0.001277362,0.0001601443,0.0005309051,0.0005604209,0.0002433367,0.000151439,0.0001807987,0.0004349356,0.0001188641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001492205,"about_ca_system_score_gemma":0.0001874427,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002737696,"about_ca_topic_score_gemma":0.002811627,"domain_scores_codex":[0.9997894,0.0000546183,0.00002174466,0.00007591082,0.00002464003,0.00003366518],"domain_scores_gemma":[0.9992825,0.0002646124,0.000258622,0.00005547901,0.00003428353,0.0001044916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006957271,0.00004055026,0.9957141,0.00001696786,0.0001947757,0.0001421592,0.00003950811,0.0001095446,0.001455962,0.0000212302,0.00005614265,0.001513436],"study_design_scores_gemma":[0.00001964479,0.0001168497,0.9990361,0.000003467151,0.0001033609,0.0001961812,0.00002148305,0.0002404323,0.0001342069,0.00004394297,0.00008199205,0.000002480192],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993528,0.0002893965,0.00006958027,0.00003029622,0.000006579348,0.000002695091,0.000135582,0.000002930593,0.0001102077],"genre_scores_gemma":[0.9997205,0.00005210431,0.00004725173,0.00001115646,0.00000639009,0.000002885366,0.0001013979,0.000001331751,0.00005694366],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002737696,"threshold_uncertainty_score":0.005443513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01292126842308376,"score_gpt":0.3100296379007363,"score_spread":0.2971083694776526,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}